A recent meta-analysis of nearly 900,000 people has added even more compelling evidence to the long list of omega-3 benefits. This study looked specifically at the association between heart disease and EPA/DHA intake. The results were published in the Mayo Clinic Proceedings January 2017 issue.
The paper is unique in that it examined the effects of omega-3s specifically upon just heart disease and coronary issues. Heart disease currently accounts for no less than half of the cardiovascular deaths in the United States today.
Omega-3 intake can reduce heart disease risk by 18 percent or more
The researchers examined 16 prospective cohort studies and 18 randomized controlled trials that involved a total of nearly 900,000 participants. They found a 6 to 18 percent reduction in risk for any type of coronary heart disease-related event, fatal or non-fatal, in those who took omega 3 fatty acids. The results underscore the importance of getting omega-3 benefits in the form of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid).
This reduction was even more significant among the most high-risk persons studied in the prospective cohort studies. The most robust association was related to sudden cardiac death, which researchers found to be as much as 47 percent reduced in those who took this essential fatty acid – on a regular basis.#novuscenter #omega3 #antiaging
Read the full article at: www.naturalhealth365.com